188 related articles for article (PubMed ID: 24577318)
21. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
Gladwin MT; Sachdev V; Jison ML; Shizukuda Y; Plehn JF; Minter K; Brown B; Coles WA; Nichols JS; Ernst I; Hunter LA; Blackwelder WC; Schechter AN; Rodgers GP; Castro O; Ognibene FP
N Engl J Med; 2004 Feb; 350(9):886-95. PubMed ID: 14985486
[TBL] [Abstract][Full Text] [Related]
22. Association of elevated tricuspid regurgitation velocity with cerebrovascular and kidney disease in children with sickle cell disease.
Ilonze C; Rai P; Galadanci N; Zahr R; Okhomina VI; Kang G; Padmanabhan D; Lebensburger J; Alishlash AS
Pediatr Blood Cancer; 2024 Jul; 71(7):e31002. PubMed ID: 38644595
[TBL] [Abstract][Full Text] [Related]
23. Haematological determinants of cardiac involvement in adults with sickle cell disease.
Damy T; Bodez D; Habibi A; Guellich A; Rappeneau S; Inamo J; Guendouz S; Gellen-Dautremer J; Pissard S; Loric S; Wagner-Ballon O; Godeau B; Adnot S; Dubois-Randé JL; Hittinger L; Galactéros F; Bartolucci P
Eur Heart J; 2016 Apr; 37(14):1158-1167. PubMed ID: 26516176
[TBL] [Abstract][Full Text] [Related]
24. Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study.
Nouraie M; Darbari DS; Rana S; Minniti CP; Castro OL; Luchtman-Jones L; Sable C; Dham N; Kato GJ; Gladwin MT; Ensing G; Arteta M; Campbell A; Taylor JG; Nekhai S; Gordeuk VR
Am J Hematol; 2020 Jul; 95(7):766-774. PubMed ID: 32243618
[TBL] [Abstract][Full Text] [Related]
25. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
[TBL] [Abstract][Full Text] [Related]
26. Right ventricular systolic strain is altered in children with sickle cell disease.
Blanc J; Stos B; de Montalembert M; Bonnet D; Boudjemline Y
J Am Soc Echocardiogr; 2012 May; 25(5):511-7. PubMed ID: 22341367
[TBL] [Abstract][Full Text] [Related]
27. Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report.
Morris CR; Kim HY; Trachtenberg F; Wood J; Quinn CT; Sweeters N; Kwiatkowski JL; Thompson AA; Giardina PJ; Boudreaux J; Olivieri NF; Porter JB; Neufeld EJ; Vichinsky EP;
Blood; 2011 Oct; 118(14):3794-802. PubMed ID: 21772051
[TBL] [Abstract][Full Text] [Related]
28. Exercise-Induced Abnormal Increase of Systolic Pulmonary Artery Pressure in Adult Patients With Sickle Cell Anemia: An Exercise Stress Echocardiography Study.
de Lima-Filho NN; Figueiredo MS; Vicari P; Cançado R; Carvalho AC; Bordin JO; Campos O
Echocardiography; 2016 Dec; 33(12):1880-1890. PubMed ID: 25521187
[TBL] [Abstract][Full Text] [Related]
29. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension.
Liem RI; Young LT; Thompson AA
Haematologica; 2007 Nov; 92(11):1549-52. PubMed ID: 18024403
[TBL] [Abstract][Full Text] [Related]
30. Prolongation of QTc intervals and risk of death among patients with sickle cell disease.
Upadhya B; Ntim W; Brandon Stacey R; Henderson R; Leedy D; O'Brien FX; Knovich MA
Eur J Haematol; 2013 Aug; 91(2):170-8. PubMed ID: 23621844
[TBL] [Abstract][Full Text] [Related]
31. Echo Doppler predictors of pulmonary artery hypertension in patients with systemic sclerosis.
Frea S; Capriolo M; Marra WG; Cannillo M; Fusaro E; Libertucci D; Morello M; Gaita F
Echocardiography; 2011 Sep; 28(8):860-9. PubMed ID: 21906161
[TBL] [Abstract][Full Text] [Related]
32. A prospective appraisal of pulmonary hypertension in children with sickle cell disease.
Sedrak A; Rao SP; Miller ST; Hekmat V; Rao M
J Pediatr Hematol Oncol; 2009 Feb; 31(2):97-100. PubMed ID: 19194191
[TBL] [Abstract][Full Text] [Related]
33. A novel molecular signature for elevated tricuspid regurgitation velocity in sickle cell disease.
Desai AA; Zhou T; Ahmad H; Zhang W; Mu W; Trevino S; Wade MS; Raghavachari N; Kato GJ; Peters-Lawrence MH; Thiruvoipati T; Turner K; Artz N; Huang Y; Patel AR; Yuan JX; Gordeuk VR; Lang RM; Garcia JG; Machado RF
Am J Respir Crit Care Med; 2012 Aug; 186(4):359-68. PubMed ID: 22679008
[TBL] [Abstract][Full Text] [Related]
34. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
35. Reproducibility of tricuspid regurgitant jet velocity measurements in children and young adults with sickle cell disease undergoing screening for pulmonary hypertension.
Liem RI; Young LT; Lay AS; Pelligra SA; Labotka RJ; Thompson AA
Am J Hematol; 2010 Oct; 85(10):741-5. PubMed ID: 20652966
[TBL] [Abstract][Full Text] [Related]
36. Splenectomy is not associated with a higher tricuspid regurgitant jet velocity in people with sickle cell anemia.
Sinha AA; Adusumilli T; Cohen HW; Nouraie M; Little J; Manwani D
Pediatr Blood Cancer; 2019 Oct; 66(10):e27928. PubMed ID: 31322833
[TBL] [Abstract][Full Text] [Related]
37. Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease.
Chaturvedi S; Labib Ghafuri D; Kassim A; Rodeghier M; DeBaun MR
Am J Hematol; 2017 Feb; 92(2):125-130. PubMed ID: 27806442
[TBL] [Abstract][Full Text] [Related]
38. Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.
Detterich JA; Kato RM; Rabai M; Meiselman HJ; Coates TD; Wood JC
Blood; 2015 Aug; 126(6):703-10. PubMed ID: 26036801
[TBL] [Abstract][Full Text] [Related]
39. Arginine Therapy and Cardiopulmonary Hemodynamics in Hospitalized Children with Sickle Cell Anemia: A Prospective, Double-blinded, Randomized Placebo-controlled Clinical Trial.
Onalo R; Cilliers A; Cooper P; Morris CR
Am J Respir Crit Care Med; 2022 Jul; 206(1):70-80. PubMed ID: 35426778
[No Abstract] [Full Text] [Related]
40. Hemolytic anemia-associated pulmonary hypertension in sickle cell disease.
Lin EE; Rodgers GP; Gladwin MT
Curr Hematol Rep; 2005 Mar; 4(2):117-25. PubMed ID: 15720960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
